96 related articles for article (PubMed ID: 9381783)
21. The endothelium: a new target for therapy.
Cooke JP
Vasc Med; 2000; 5(1):49-53. PubMed ID: 10737156
[TBL] [Abstract][Full Text] [Related]
22. Primary endothelial dysfunction: atherosclerosis.
Shimokawa H
J Mol Cell Cardiol; 1999 Jan; 31(1):23-37. PubMed ID: 10072713
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of disease: L-arginine in coronary atherosclerosis--a clinical perspective.
Tousoulis D; Böger RH; Antoniades C; Siasos G; Stefanadi E; Stefanadis C
Nat Clin Pract Cardiovasc Med; 2007 May; 4(5):274-83. PubMed ID: 17457351
[TBL] [Abstract][Full Text] [Related]
24. Arginase inhibition improves endothelial function in patients with coronary artery disease and type 2 diabetes mellitus.
Shemyakin A; Kövamees O; Rafnsson A; Böhm F; Svenarud P; Settergren M; Jung C; Pernow J
Circulation; 2012 Dec; 126(25):2943-50. PubMed ID: 23183942
[TBL] [Abstract][Full Text] [Related]
25. Impaired NO-dependent vasodilation in patients with Type II (non-insulin-dependent) diabetes mellitus is restored by acute administration of folate.
van Etten RW; de Koning EJ; Verhaar MC; Gaillard CA; Rabelink TJ
Diabetologia; 2002 Jul; 45(7):1004-10. PubMed ID: 12136399
[TBL] [Abstract][Full Text] [Related]
26. Nitric oxide and the mediation of the hemodynamic effects of growth hormone in humans.
Böger RH
J Endocrinol Invest; 1999; 22(5 Suppl):75-81. PubMed ID: 10442575
[TBL] [Abstract][Full Text] [Related]
27. Acute administration of L-arginine does not improve arterial endothelial function in chronic renal failure.
Cross JM; Donald AE; Kharbanda R; Deanfield JE; Woolfson RG; MacAllister RJ
Kidney Int; 2001 Dec; 60(6):2318-23. PubMed ID: 11737605
[TBL] [Abstract][Full Text] [Related]
28. L-arginine induces nitric oxide-dependent vasodilation in patients with critical limb ischemia. A randomized, controlled study.
Bode-Böger SM; Böger RH; Alfke H; Heinzel D; Tsikas D; Creutzig A; Alexander K; Frölich JC
Circulation; 1996 Jan; 93(1):85-90. PubMed ID: 8616947
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms and prevention of intimal thickening of the autogenous vein grafts--possible involvement of nitric oxide--.
Komori K
Nagoya J Med Sci; 2003 May; 66(1-2):9-19. PubMed ID: 12848417
[TBL] [Abstract][Full Text] [Related]
30. Endothelial dysfunction and atherothrombotic occlusive disease.
Freedman JE; Loscalzo J
Drugs; 1997; 54 Suppl 3():41-9; discussion 49-50. PubMed ID: 9360851
[TBL] [Abstract][Full Text] [Related]
31. L-arginine and atherothrombosis.
Loscalzo J
J Nutr; 2004 Oct; 134(10 Suppl):2798S-2800S; discussion 2818S-2819S. PubMed ID: 15465788
[TBL] [Abstract][Full Text] [Related]
32. The L-arginine-nitric oxide pathway: role in atherosclerosis and therapeutic implications.
Böger RH; Bode-Böger SM; Frölich JC
Atherosclerosis; 1996 Nov; 127(1):1-11. PubMed ID: 9006798
[No Abstract] [Full Text] [Related]
33. Vasoprotection by nitric oxide: mechanisms and therapeutic potential.
Gewaltig MT; Kojda G
Cardiovasc Res; 2002 Aug; 55(2):250-60. PubMed ID: 12123764
[TBL] [Abstract][Full Text] [Related]
34. [Pathophysiological and clinical aspects of using L-arginine in cardiology and angiology].
Valeev VV; Trashkov AP; Kovalenko AL; Vasil'ev AG
Angiol Sosud Khir; 2016; 22(3):9-15. PubMed ID: 27626244
[TBL] [Abstract][Full Text] [Related]
35. Coronary vasospasm in humans: the role of atherosclerosis and of impaired endothelial vasodilator function.
Ganz P; Weidinger FF; Yeung AC; Vekshtein VI; Vita JA; Ryan TJ; McLenachan JM; Selwyn AP
Basic Res Cardiol; 1991; 86 Suppl 2():215-22. PubMed ID: 1953613
[No Abstract] [Full Text] [Related]
36. Effect of diet on vascular reactivity: an emerging marker for vascular risk.
West SG
Curr Atheroscler Rep; 2001 Nov; 3(6):446-55. PubMed ID: 11602064
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis and treatment of endothelial dysfunction in cardiovascular disease.
Hirata Y; Nagata D; Suzuki E; Nishimatsu H; Suzuki J; Nagai R
Int Heart J; 2010 Jan; 51(1):1-6. PubMed ID: 20145343
[TBL] [Abstract][Full Text] [Related]
38. Endothelial cell function testing: how does the method help us in evaluating vascular status?
Halcox JP; Deanfield JE
Acta Paediatr Suppl; 2004 Dec; 93(446):48-54. PubMed ID: 15702670
[TBL] [Abstract][Full Text] [Related]
39. [Anti-arteriosclerosis effects due to stimulation of endogenous nitric oxide synthesis].
Bode-Böger SM; Böger RH; Frölich JC
Internist (Berl); 1997 May; 38(5):461-5. PubMed ID: 9264983
[No Abstract] [Full Text] [Related]
40. Atherogenesis--recent insights into basic mechanisms and their clinical impact.
Schächinger V; Zeiher AM
Nephrol Dial Transplant; 2002 Dec; 17(12):2055-64. PubMed ID: 12454211
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
